COMPARATIVE PHARMACEUTICAL EVALUATION OF VARIABLE RETAIL PRICED MEDICINES CONTAINING BIOPHARMACEUTICAL CLASSIFICATION SYSTEM CLASS-II OR CLASS-IV DRUGS

Author:

Soni Mahesh S.,Pawar Atmaram P.,Bothiraja Chellampillai,Gaikwad Vinod L., ,

Abstract

The purpose of the present study is to highlight the discriminations if any, between the quality of low and high-cost medicines, which would help to select the right brand of medicine. In the present work, brands of medicines having high, medium, and low prices containing either of biopharmaceutical classification system class-II or class-IV drugs were comparatively evaluated for different pharmacopoeial standards as well as for biopharmaceutical classification system solubility and permeability. An ex vivo permeability test was carried out using a simple and non-invasive everted gut sac technique. Insignificant variation in pharmaceutical quality and permeability of the tested three types of brands was observed; however, the study could not consider the state of quality assurance facilities and parameters used while manufacturing these medicines. The study will help to make aware and assure medical and pharmacy practitioners and consumers for the selection of quality quality generic medicines.

Publisher

Indian Drug Manufacturers' Association (IDMA)

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Reference30 articles.

1. 1. Swain S, Dey A, Patra CN, Rao MEB. Pharma regulations for generic drug products in India and US: Case studies and future prospectives. Pharm Regul Aff Open Access. 2014;03(02):1-6. doi:10.4172/2167-7689.1000119

2. 2. Tamboli AM, Todkar P, Zope P, Sayyad FJ. An overview on bioequivalence: Regulatory consideration for generic drug products. J Bioequiv Availab. 2010;02(04):086-092. doi:10.4172/jbb.1000037

3. 3. Soans A. Quality, Not Price, is the Key Issue When Prescribing Generic Drugs in India. The Wire Health. https://thewire.in/health/drugs-generics-branded-health. Published 2017. Accessed February 26, 2019.

4. 4. Reddy Mallu U, Karanam S, Srinath Reddy P. ANDA paragraph-IV filings: A complete review. Int J Sci Innov Discov. 2012;2(4):96-112.

5. 5. Scientific American. What’s the difference between brand-name and generic prescription drugs? Health, Scientific American. https://www.scientificamerican.com/article/whats-the-difference-betw-2004-12-13/. Published 2004. Accessed February 26, 2019.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3